Pharmacists do not need to check prescriptions written by every nurse for formulary compliance
Community pharmacists do not need to police formulary compliance by extended formulary and supplementary nurse prescribers, according to guidance issued by London, Eastern and South East Specialist Pharmacy Services. However, they do need to continue to check prescribing by district nurses and health visitors.
Beth Taylor, specialist principal pharmacist,
explained that the guidance aims to help prevent unnecessary queries
of nurse-written prescriptions. “We are getting feedback that pharmacists
have been finding it difficult since the introduction of supplementary
prescribing because both extended formulary and supplementary prescriber
nurses are writing prescriptions on the same forms,” she said. “The
guidance aims to reassure community pharmacists that they need to be
clinically screening the prescription in the normal way and that they
are not expected to police formulary compliance for extended formulary
nurse prescribers.”
The guidance was taken from a Department of Health publication about
the implementation of nurse prescribing. It says that it is not possible
to distinguish between prescriptions written by extended formulary nurse
prescribers and supplementary prescribers. Since supplementary prescribers
do not have to prescribe according to a specific formulary, pharmacists
do not need to check that these prescriptions comply with the nurse formulary.
However, pharmacists are still expected to check that prescriptions written
by district nurses or health visitor nurse prescribers (on form FP10
P) are within the current nurse formulary.
Regarding extended formulary and supplementary prescribers, the guidance
states: “The dispensing pharmacist has accountability for ensuring
the usual prescription requirements apply, eg, signature, date. However,
it is the prescriber who is accountable for their own actions should
they prescribe outside their clinical area, and employing organisations
are expected to have clinical governance systems in place to monitor
all prescribing activity.” |